EPISODE · Mar 18, 2025 · 52 MIN
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
from Few & Far Between: How Biotech Gets Built · host Chris O'Brien
Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases. Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role. Tune in today!
What this episode covers
Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases. Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role. Tune in today!
NOW PLAYING
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
No transcript for this episode yet
Similar Episodes
Feb 1, 2025 ·168m
Aug 7, 2024 ·58m
Jun 15, 2022 ·8m